Katie Anderson 450 450 headshot

Katie Anderson

Katie brings nearly two decades of editorial experience in business-to-business media. After earning her master’s degree in journalism, she began her career at the personal care R&D trade journal Cosmetics & Toiletries. There, she thrived on the constant flow of knowledge gained from interviewing chemists, regulatory experts, formulators and testing professionals in the field.

After nearly eight years with Cosmetics & Toiletries, Katie pursued her passion for skin physiology and ingredient science as Managing Editor of the professional esthetics brand Skin Inc. That same year, she also took on the role of Conference Director for Face and Body, where she developed and managed the event’s educational programming.

Following an acquisition, Katie was promoted to Editor-in-Chief of five professional media brands: Nailpro, Skin Inc., Beauty Launchpad, Medical Esthetics, and WellSpa 360.

Throughout her 19-year editorial career, Katie has held a variety of roles, but her passion has always been scientific editorial. She is the recipient of a bronze Folio Eddie Award for a single science article. She has frequently contributed her expertise as a guest speaker on industry podcasts, webcasts, conferences and video interviews. A lifelong learner, she enjoys the challenge of translating complex technical content into material that is both accurate and accessible.

Connect with Katie on LinkedIn: https://www.linkedin.com/in/katieanderson121/

ARTICLES BY KATIE ANDERSON

  • AI In Action: Evaluating Project Assessment
    11/9/2026

    In this four-part series of interviews at ISPE’s Annual Meeting & Expo, I talk to experts who have made advances in AI, all in different areas, to do their job more efficiently. We explore project assessment here, but will also explore cleaning validation, continuous verification and risk assessment in future segments.

  • Modulus Brings Home Top Award At 2026 FOYAs
    10/31/2026

    The ingenuity on display went well beyond the latest equipment. From technological innovation and operational excellence to sustainability and supply chain solutions, the FOYAs celebrated how facility design brings these pieces together to create a superior working environment.

  • Designing Pharma Facilities For Change, Not Just Capacity
    10/28/2026

    Pharmaceutical innovation is making drug manufacturing more complex—and placing new demands on facility design. Accommodating today’s processes is no longer enough. Facilities must also be able to change. Modular design offers a way to build that adaptability into the facility itself.

  • Why Early Evaluation Of Process Parameters Matters In OSD Scale-Up
    10/26/2026

    For oral solid dose (OSD) manufacturers, technology transfer often becomes an exercise in managing uncertainty. Differences in equipment, blending conditions, material properties, and tooling design can introduce challenges that may not become apparent until later-stage development or even commercial scale-up.

  • Printing A New Path To The Brain: 3D Buccal Nanofilms For CNS Lymphoma
    10/19/2026

    Though methotrexate is the most effective therapeutic against primary central nervous system (CNS) lymphoma, it can cause toxicity issues at therapeutic concentrations. Aditi Suchitkumar Satoskar and her research team at Mercer University sought to look for alternatives, investigating a noninvasive approach that combines methotrexate-loaded bovine serum albumin nanoparticles, an RVG-derived brain-targeting peptide, and a 3D-printed buccal film.

  • Capturing Tablet Disintegration for Improved OSD Development
    10/15/2026

    Closed-loop laboratory automation promises to make oral solid dosage form development faster and more efficient, but the behavior of powders, tablets and dissolution processes remains difficult to predict.

  • Why CMC Tech Transfer Should Begin With The End In Mind
    10/1/2026

    This interview with Sai Life Sciences’ Tuneer Ghosh explains why CMC technology transfer should begin with commercialization and lifecycle goals in mind. It highlights how early planning for scale, CDMO involvement, supply resilience, regulatory requirements, process safety, and shared learning can support a smoother, more sustainable transfer.

  • 4 Ways To Build A Better CMC Tech Transfer
    9/23/2026

    A technology transfer can falter long before a process reaches the plant. Gaps in process knowledge, mismatched equipment, and insufficient scale-up data can all undermine reproducibility, timelines, and cost.

  • AI Governance Is Just Like Driving A Race Car
    9/1/2026

    Though some skeptics remain, nearly every business is at some stage of AI adoption. The technology has proven applications in pharmaceutical manufacturing, but effective governance must keep pace with its rapid development. That challenge is familiar to Bill Reid, healthcare and life sciences lead in Google’s Chief Information Security Office (CISO).

  • Can U.S. Policy Bring Generic Drug Manufacturing Back Home?
    8/25/2026

    Generic medicines imported into the U.S. were not subject to the recently imposed tariffs on imported pharmaceuticals, but President Trump posted in July that this could change within two years.